Stephen V. Carney
Impact in
- Genetics top 2%
- Glioma Diagnosis and Treatment
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 11
- Glioma Diagnosis and Treatment 11
- Virus-based gene therapy research 2
-
- Immune cells in cancer 3
- interferon and immune responses 2
- Immunotherapy and Immune Responses 2
- Co-authors
- Pedro Ricardo Lowenstein (9 shared papers)Maria Graciela Castro (10 shared papers)Santiago Haase (7 shared papers)Felipe Javier Núñez (8 shared papers)María Belén Garcia-Fabiani (6 shared papers)Flor Mendez (3 shared papers)Fernando M. Núñez (3 shared papers)David B. Altshuler (3 shared papers)
- Journals
- Journal of Clinical Investigation (2 papers)Clinical Cancer Research (2 papers)Trends in Biochemical Sciences (1 paper)Neuro-Oncology (1 paper)Expert Opinion on Biological Therapy (1 paper)
- Partner nations
- United StatesArgentina
In The Last Decade
Stephen V. Carney
17 papers receiving 938 citations
Peers
Comparison fields: 5 of 70
- Genetics 424
- Cancer Research 182
- Immunology 223
- Oncology 178
- Neurology 49
Countries citing papers authored by Stephen V. Carney
This map shows the geographic impact of Stephen V. Carney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen V. Carney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen V. Carney more than expected).
Fields of papers citing papers by Stephen V. Carney
This network shows the impact of papers produced by Stephen V. Carney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen V. Carney. The network helps show where Stephen V. Carney may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen V. Carney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 197 | |
| 2 | 2018 | 118 | |
| 3 | 2022 | 118 | |
| 4 | 2020 | 115 | |
| 5 | 2021 | 72 | |
| 6 | 2021 | 66 | |
| 7 | 2021 | 66 | |
| 8 | 2022 | 58 | |
| 9 | 2017 | 28 | |
| 10 | 2019 | 20 | |
| 11 | 2021 | 20 | |
| 12 | 2020 | 19 | |
| 13 | 2020 | 19 | |
| 14 | 2020 | 13 | |
| 15 | 2023 | 7 | |
| 16 | 2024 | 6 | |
| 17 | 2019 | 2 |
About Stephen V. Carney
Stephen V. Carney is a scholar working on Genetics, Immunology, Oncology, Biotechnology and Cancer Research, having authored 17 papers that have together received 944 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (11 papers), Epigenetics and DNA Methylation (3 papers), Immune cells in cancer (3 papers), interferon and immune responses (2 papers), Cancer Research and Treatments (2 papers), Immunotherapy and Immune Responses (2 papers), Virus-based gene therapy research (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Genetics (424 citations), Cancer Research (182 citations), Immunology (223 citations), Oncology (178 citations) and Neurology (49 citations). Stephen V. Carney has collaborated with scholars based in United States and Argentina. Frequent co-authors include Pedro Ricardo Lowenstein, Maria Graciela Castro, Santiago Haase, Felipe Javier Núñez, María Belén Garcia-Fabiani, Flor Mendez, Fernando M. Núñez, David B. Altshuler, Mahmoud S. Alghamri and Syed Mohd Faisal. Their work appears in journals such as Journal of Clinical Investigation, Clinical Cancer Research, Trends in Biochemical Sciences, Neuro-Oncology and Expert Opinion on Biological Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.